Global Veterinary Medicine Market Overview to 2027

0

DUBLIN, July 15, 2022 /PRNewswire/ — The “Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to from ResearchAndMarkets.com offer.

The global veterinary medicine market reached a value of US$31.06 billion in 2021. Looking ahead, the publisher expects the market to reach a value of US$48.58 billion by 2027, posting a CAGR of 7.74% over the period 2021-2027. Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic on different end-use sectors. This information is included in the report as a major market contributor.

Veterinary medicine is a branch of science that deals with the prevention, control, diagnosis and treatment of diseases that affect the health of domestic and wild animals. It helps maintain the health of food-producing animals, inhibit the transmission of zoonotic diseases from animal species to humans, and ensure a safe food supply worldwide. Currently, the growing consumption of animal products is increasing the adoption of veterinary drugs to monitor farm animal health and prevent human exposure to disease.

The growing trend of nuclear families and inflation of income levels has increased the overall spending of individuals on pets around the world. This, in conjunction with pet owners’ growing concern for the welfare of their pets, represents one of the major factors supporting the demand for veterinary drugs.

The increasing penetration of pet insurance is further influencing the growth of the market. Apart from this, the expansion of livestock activities, as well as the increase in cases of zoonotic and chronic diseases in animals, increase the concerns about food safety. This, along with the growing number of commercial animal production programs, is driving the adoption of veterinary drugs for better diagnosis and treatment of livestock.

Additionally, the easy availability of advanced diagnostic imaging, new therapies, nuclear and regenerative drugs, laser diagnostics, and specialized surgeries in many hospitals and veterinary clinics is bolstering the growth of the market. Additionally, biomedical researchers are developing safe and effective vaccines to prevent pet diseases, which is expected to enhance the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the major players being Archer-Daniels-Midland Company, Boehringer Ingelheim GmbH, Cargill Incorporated, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Merck & Co. Inc., Neogen Corporation, Vetoquinol SA, Virbac and Zoetis Inc.

Answers to key questions in this report:

  • How has the global veterinary medicine market behaved so far and how will it behave in the years to come?
  • What has been the impact of COVID-19 on the global veterinary medicine market?
  • What are the main regional markets?
  • What is the market breakdown by product?
  • What is the breakdown of the market according to the type of animal?
  • What is the market breakdown by route of administration?
  • What is the market breakdown by distribution channel?
  • What are the different stages of the industry value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global veterinary medicine market and who are the major players?
  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Medicine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakdown by Product
6.1 Medicines
6.1.1 Market trends
6.1.2 Key segments
6.1.2.1 Anti-infectives
6.1.2.2 Anti-inflammatory
6.1.2.3 Parasiticide
6.1.3 Market Forecast
6.2 Vaccines
6.2.1 Market trends
6.2.2 Key segments
6.2.2.1 Inactivated vaccines
6.2.2.2 Attenuated vaccines
6.2.2.3 Recombinant vaccines
6.2.3 Market Forecast
6.3 Medicated food additives
6.3.1 Market trends
6.3.2 Key segments
6.3.2.1 Amino acids
6.3.2.2 Antibiotics
6.3.3 Market Forecast

7 Market Breakdown by Animal Type
7.1 Manufacturing
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Companion
7.2.1 Market trends
7.2.2 Market Forecast

8 Market Breakdown by Jurisdiction
8.1 Oral
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market trends
8.2.2 Market Forecast
8.3 Topical
8.3.1 Market trends
8.3.2 Market Forecast

9 Market Breakdown by Distribution Channel
9.1 Veterinary hospitals and clinics
9.1.1 Market trends
9.1.2 Market Forecast
9.2 Point-of-Care Testing/In-house Testing
9.2.1 Market trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market trends
9.3.2 Market Forecast

10 Market Breakdown by Region

11 SWOT Analysis

12 Value chain analysis

13 Analysis of the five forces of carriers

14 Price Analysis

15 Competitive Landscape
15.1 Market structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Archer-Daniels-Midland Company
15.3.1.1 Company Overview
15.3.1.2 Product portfolio
15.3.1.3 Finance
15.3.1.4 SWOT Analysis
15.3.2 Boehringer Ingelheim GmbH
15.3.2.1 Presentation of the company
15.3.2.2 Product portfolio
15.3.3 Cargill Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product portfolio
15.3.3.3 SWOT Analysis
15.3.4 Ceva Animal Health
15.3.4.1 Company Overview
15.3.4.2 Product portfolio
15.3.5 Dechra Pharmaceuticals PLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Finance
15.3.6 Elanco Animal Health Incorporated
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Finance
15.3.7 Evonik Industries SA
15.3.7.1 Company Overview
15.3.7.2 Product portfolio
15.3.7.3 Finance
15.3.8 Merck & Co. Inc.
15.3.8.1 Company Overview
15.3.8.2 Product portfolio
15.3.8.3 Finance
15.3.9 Neogen Corporation
15.3.9.1 Company Overview
15.3.9.2 Product portfolio
15.3.9.3 Finance
15.3.9.4 SWOT Analysis
15.3.10 Vetoquinol SA
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Finance
15.3.11 Virbac
15.3.11.1 Company Overview
15.3.11.2 Product portfolio
15.3.11.3 Finance
15.3.11.4 SWOT Analysis
15.3.12 Zoetis Inc.
15.3.12.1 Company Overview
15.3.12.2 Product portfolio
15.3.12.3 Finance
15.3.12.4 SWOT Analysis

For more information on this report, visit https://www.researchandmarkets.com/r/kpoq5l

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Share.

Comments are closed.